Meclizine Does Not Cause Hypoglycemia
Meclizine is not associated with hypoglycemia and can be used safely without concern for lowering blood glucose levels. The FDA drug label for meclizine does not list hypoglycemia as an adverse effect, and the documented side effects are limited to anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, vomiting, and rarely blurred vision 1.
Evidence from FDA Drug Labeling
The official FDA prescribing information for meclizine provides comprehensive safety data and makes no mention of hypoglycemia as either a common or rare adverse effect 1. The drug label details:
- Known adverse reactions: drowsiness, dry mouth, headache, fatigue, vomiting, blurred vision, and anaphylactic reactions
- Mechanism of action: H1 histamine receptor antagonist
- Metabolism: primarily via CYP2D6 enzyme
- No metabolic effects on glucose: The pharmacodynamic profile shows no relevant effects on glucose metabolism 1
Systematic Review of Drug-Induced Hypoglycemia
A comprehensive 2009 systematic review examined 448 studies describing 2,696 cases of hypoglycemia associated with 164 different drugs 2. Meclizine was not identified among the drugs causing hypoglycemia. The most commonly implicated non-diabetic drugs were:
- Quinolones
- Pentamidine
- Quinine
- Beta blockers
- ACE inhibitors
- IGF
The absence of meclizine from this extensive review further confirms its safety profile regarding glucose metabolism.
Clinical Context
When evaluating hypoglycemia in clinical practice, the Endocrine Society guidelines emphasize focusing on established causes 3:
- Diabetic medications: sulfonylureas, insulin, repaglinide
- Alcohol: inhibits gluconeogenesis
- Endocrine insufficiency: cortisol or growth hormone deficiency
- Insulinoma: though rare
Meclizine should not be considered in the differential diagnosis of unexplained hypoglycemia, as there is no evidence linking it to glucose disturbances.
Practical Implications
If a patient taking meclizine develops hypoglycemia, investigate other causes rather than attributing it to the antihistamine. Look for:
- Concurrent use of actual hypoglycemic agents
- Alcohol consumption
- Fasting states
- Underlying endocrine disorders
- Other medications from the established list of hypoglycemia-inducing drugs 4, 2
The drug can be safely continued in patients with diabetes or those at risk for hypoglycemia without additional glucose monitoring requirements.